These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3627106)

  • 21. Vitamin K-dependent carboxylase: partial purification of the enzyme by antibody affinity techniques.
    Harbeck MC; Cheung AY; Suttie JW
    Thromb Res; 1989 Oct; 56(2):317-23. PubMed ID: 2617472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle.
    Thijssen HH; Soute BA; Vervoort LM; Claessens JG
    Thromb Haemost; 2004 Oct; 92(4):797-802. PubMed ID: 15467911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K-dependent carboxylase: inhibitory action of polychlorinated phenols.
    Grossman CP; Suttie JW
    Biochem Pharmacol; 1990 Sep; 40(6):1351-5. PubMed ID: 2403388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural prenylquinones inhibit the enzymes of the vitamin K cycle in vitro.
    Ronden JE; Soute BA; Thijssen HH; Saupe J; Vermeer C
    Biochim Biophys Acta; 1996 Nov; 1298(1):87-94. PubMed ID: 8948492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin K-antagonistic effect of plastoquinone and ubiquinone derivatives in vitro.
    Saupe J; Ronden JE; Soute BA; Vermeer C
    FEBS Lett; 1994 Jan; 338(2):143-6. PubMed ID: 8307171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Hutson SM
    Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X.
    Sun YM; Jin DY; Camire RM; Stafford DW
    Blood; 2005 Dec; 106(12):3811-5. PubMed ID: 16081695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Sane DC; Hutson SM
    Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay of vitamin K-dependent carboxylase activity in hepatic and extrahepatic tissues.
    Houben RJ; Soute BA; Vermeer C
    Methods Enzymol; 1997; 282():358-68. PubMed ID: 9330301
    [No Abstract]   [Full Text] [Related]  

  • 33. Vitamin K-dependent carboxylases from non-hepatic tissues.
    Vermeer C; Hendrix H; Daemen M
    FEBS Lett; 1982 Nov; 148(2):317-20. PubMed ID: 7152026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent findings in understanding the biological function of vitamin K.
    Uotila L; Suttie JW
    Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC; Suttie JW
    Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows.
    Vermeer C; Soute BA; De Metz M; Hemker HC
    Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin K-dependent coagulation factors deficiency.
    Brenner B; Kuperman AA; Watzka M; Oldenburg J
    Semin Thromb Hemost; 2009 Jun; 35(4):439-46. PubMed ID: 19598072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental expression of vitamin K-dependent gamma-carboxylase activity in zebrafish embryos: effect of warfarin.
    Hanumanthaiah R; Thankavel B; Day K; Gregory M; Jagadeeswaran P
    Blood Cells Mol Dis; 2001; 27(6):992-9. PubMed ID: 11831865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.